ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.61333
-0.05%
Brent Oil
82.20
-0.30%
Bitcoin
69,891.73
-0.34%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Obalon Therapeutics Inc (OBLN)

  7. Obalon Therapeutics Inc (OBLN) Noticias

OBLN

Obalon Therapeutics (OBLN)

Obalon Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OBLN
FechaHoraFuenteTítuloSímboloCompañía
16/05/202305:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OBLNObalon Therapeutics Inc
15/05/202316:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OBLNObalon Therapeutics Inc
24/04/202308:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OBLNObalon Therapeutics Inc
03/04/202316:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:OBLNObalon Therapeutics Inc
17/03/202316:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OBLNObalon Therapeutics Inc
14/02/202312:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OBLNObalon Therapeutics Inc
08/02/202308:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202308:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202305:05Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:OBLNObalon Therapeutics Inc
12/01/202316:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:OBLNObalon Therapeutics Inc
20/12/202215:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OBLNObalon Therapeutics Inc
10/11/202215:56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OBLNObalon Therapeutics Inc
31/10/202215:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OBLNObalon Therapeutics Inc
26/08/202215:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OBLNObalon Therapeutics Inc
16/08/202205:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OBLNObalon Therapeutics Inc
22/03/202205:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OBLNObalon Therapeutics Inc
21/09/202115:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OBLNObalon Therapeutics Inc
03/09/202115:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OBLNObalon Therapeutics Inc
21/05/202108:00Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OBLNObalon Therapeutics Inc
12/05/202107:40GlobeNewswire Inc.Obalon Announces First Quarter 2021 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
09/04/202116:22Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OBLNObalon Therapeutics Inc
30/03/202105:11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OBLNObalon Therapeutics Inc
15/03/202109:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OBLNObalon Therapeutics Inc
12/03/202118:12GlobeNewswire Inc.Obalon Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
03/02/202116:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OBLNObalon Therapeutics Inc
06/11/202015:45GlobeNewswire Inc.Obalon Announces Third Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
25/09/202015:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OBLNObalon Therapeutics Inc
01/09/202015:55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OBLNObalon Therapeutics Inc
13/08/202006:00GlobeNewswire Inc.Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon SystemNASDAQ:OBLNObalon Therapeutics Inc
30/07/202005:38GlobeNewswire Inc.Obalon Announces Second Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OBLN

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
CCOM
OILBRENT
Brent Oil
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
AXP
American Express
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
NYSE
BAC
Bank of America
FX
EURUSD
Euro vs US Dollar
AMEX
SPY
SPDR S&P 500
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados